Rhabdomyosarcoma of the Head and Neck in Children

Abstract
Three of"" 7 are alive and well 24 months to seven years postoperatively. One of them had what was thought to be a complete excision at the time of operation and received no adjunct to surgical therapy. The other two had known incomplete radical resections, and had as added therapy intra-arterial infusion at the time of surgery as well as postoperative anti-cancer chemotherapy. The drug used was Actinomycin D in one case, and Mitomycin C in the other. (All patients have survived an additional 11 months.).